Johnson & Johnson (JNJ) stock
Last close $267.14 on 2026-11-19 (-2.04%) · Sector: Healthcare
Johnson & Johnson is a large American healthcare company founded in 1886. It makes prescription medicines, medical devices, and consumer health products, and it earns money by selling these products to hospitals, doctors, pharmacies, and shoppers.
Johnson & Johnson still shows steady sales growth, with revenue up 7.8% over the past year and a gross margin (the share of sales left after direct product costs) of about 67.5%. The stock has returned 31.6% over the past year, well ahead of the S&P 500's 9.7%, though it sits 8.0% below its 52-week high. Insiders sold $12.9M of stock in the last 90 days and made no purchases, and the stock fell the day after 3 of its last 4 earnings reports.
Key numbers
- Market cap: $654.1B
- Revenue (last 12 months): $99.33B
- Revenue growth: +7.8%
- Gross margin: 67.5%
- P/E: 40.6
- P/S: 6.6
- Debt to equity: 0.44
- Current ratio: 1.02
Quality score
Overall 29/100 · growth 36 · profitability None · financial health 51 · value 0
Performance and risk
1-year return +31.6% vs S&P 500 +9.7% · volatility 21.4% (S&P 500 13.8%) · largest drop -11.0% · beta -0.02
Stock move the day after earnings
- 2026-01-21: -0.1%
- 2026-04-14: +0.9%
- 2026-07-15: -2.7%
- 2026-10-13: -5.7%
Congress trades (90 days)
2 buys, 2 sells
Insider trades (12 months)
Bought $0.3M · sold $154.4M
JNJ stock research · JNJ options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.